CureVac
Dr. Marco Rau currently serves as General Counsel and Executive Vice President of Legal & Compliance at CureVac, a role held since March 2021, after previously serving as Senior Vice President in the same department. Prior to joining CureVac, Dr. Rau was with Merck KGaA in Germany from August 2017 to March 2021 as Head of Legal Strategy & Transformation, and held various legal positions within the Merck Group from 2013 to 2017. Dr. Rau's early career includes roles at Telefónica O2 Germany, Buse Heberer Fromm Rechtsanwälte, and Beiten Burkhardt, focusing on IT/IP law and related fields. Dr. Rau holds multiple advanced degrees, including an Executive MBA from ESSEC Business School and Mannheim Business School, an LL.M. in IP from Queen Mary University of London, and a Doctorate in Law from Johannes Gutenberg University Mainz, among others.
This person is not in the org chart
This person is not in any teams
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.